SpaceX’s massive Starship rocket, central to Elon Musk’s vision for interplanetary travel, launched its ninth uncrewed test flight from Starbase, Texas, on May 27, 2025. The two-stage vehicle—comprising the upper-stage Starship mounted on the Super Heavy booster—blasted off at 7:36 p.m. EDT, soaring higher than previous attempts that ended in fiery failures.
For the first time, SpaceX used a previously flown Super Heavy booster, aiming to prove its reusability. The 232-foot rocket successfully separated from the upper stage several minutes after liftoff. However, SpaceX lost contact with the booster during descent, and it did not achieve its planned controlled splashdown.
Meanwhile, the Starship upper stage continued into space, reaching its intended suborbital trajectory about nine minutes post-launch. The mission encountered trouble when Starship’s payload doors failed to open, preventing the release of simulated satellites. Despite the issue, the vehicle continued toward atmospheric re-entry.
Roughly 30 minutes after liftoff, SpaceX reported that Starship had lost attitude control and began spinning. “Our chances of making it all the way down are pretty slim,” said a SpaceX commentator during the livestream.
The mission was designed to last under 90 minutes, concluding with a controlled splashdown in the Indian Ocean. Despite the setbacks, the test marks another step in the development of the fully reusable launch system intended for future Moon and Mars missions.
With each test, SpaceX gathers valuable data as it pushes the boundaries of next-generation spaceflight technology. Starship remains central to NASA’s Artemis program and Musk’s broader goal of making humanity multiplanetary. While challenges persist, each flight brings Starship closer to its operational debut.


Microsoft Unveils Massive Global AI Investments, Prioritizing India’s Rapidly Growing Digital Market
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
IBM Nears $11 Billion Deal to Acquire Confluent in Major AI and Data Push
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Australia Enforces World-First Social Media Age Limit as Global Regulation Looms
SpaceX CEO Elon Musk Denies Reports of $800 Billion Valuation Fundraise
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Nvidia Develops New Location-Verification Technology for AI Chips
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
Air Transat Reaches Tentative Agreement With Pilots, Avoids Strike and Restores Normal Operations
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up 



